These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4094894)

  • 1. [The radiosensitizing effects of misonidazole and/or 5FU on C3H mouse mammary carcinoma].
    Hasegawa R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1270-7. PubMed ID: 4094894
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
    Horsman MR; Overgaard J; Chaplin DJ
    Acta Oncol; 1988; 27(6b):861-2. PubMed ID: 3233175
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
    Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined effects of radiotherapy and hyperthermia on C3H/He mouse mammary carcinoma].
    Okabe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Oct; 45(10):1377-85. PubMed ID: 4088847
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K; Takahashi M; Hamanaka D; Hiraoka M; Nishidai T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):370-6. PubMed ID: 6223274
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
    Suit HD; Brown JM
    Br J Radiol; 1979 Feb; 52(614):159-60. PubMed ID: 427373
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
    Suit HD; Sedlacek R; Silver G; Hsieh CC; Epp ER; Ngo FQ; Roberts WK; Verhey L
    Radiat Res; 1988 Dec; 116(3):482-502. PubMed ID: 3205910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of local tumour control by misonidazole and hyperthermia.
    Stone HB
    Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo study.
    Demange L; Carpentier Y; Loirette M; Hivet J; Rigaud C; Desoize B
    Anticancer Res; 1993; 13(6A):2181-6. PubMed ID: 8297132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
    Ono K; Komuro C; Nishidai T; Shibamoto Y; Dodo Y; Takahashi M; Abe M; Shrieve DC
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1843-7. PubMed ID: 3759535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined use of amifostine and misonidazole in experimental radiotherapy].
    Tsukiyama I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Apr; 43(4):613-21. PubMed ID: 6310492
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
    Goldfeder A; Brown DM; Berger A
    Cancer Res; 1979 Aug; 39(8):2966-70. PubMed ID: 455281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
    Mao HS; Grau C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):115-22. PubMed ID: 1727107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.